Clonal evolution of acute leukemia genomes
Open Access
- 20 February 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 32 (2), 135-140
- https://doi.org/10.1038/onc.2012.48
Abstract
In large part, cancer results from the accumulation of multiple mutations in a single cell lineage that are sequentially acquired and subject to an evolutionary process where selection drives the expansion of more fit subclones. Owing to the technical challenge of distinguishing and isolating distinct cancer subclones, many aspects of this clonal evolution are poorly understood, including the diversity of different subclones in an individual cancer, the nature of the subclones contributing to relapse, and the identity of pre-cancerous mutations. These issues are not just important to our understanding of cancer biology, but are also clinically important given the need to understand the nature of subclones responsible for the refractory and relapsed disease that cause significant morbidity and mortality in patients. Recently, advanced genomic techniques have been used to investigate clonal diversity and evolution in acute leukemia. Studies of pediatric acute lymphoblastic leukemia (ALL) demonstrated that in individual patients there are multiple genetic subclones of leukemia-initiating cells, with a complex clonal architecture. Separate studies also investigating pediatric ALL determined that the clonal basis of relapse was variable and complex, with relapse often evolving from a clone ancestral to the predominant de novo leukemia clone. Additional studies in both ALL and acute myeloid leukemia have identified pre-leukemic mutations in some individual cases. This review will highlight these recent reports investigating the clonal evolution of acute leukemia genomes and discuss the implications for clinical therapy.Keywords
This publication has 56 references indexed in Scilit:
- Use of Whole-Genome Sequencing to Diagnose a Cryptic Fusion OncogeneJama-Journal Of The American Medical Association, 2011
- Identification of a Novel TP53 Cancer Susceptibility Mutation Through Whole-Genome Sequencing of a Patient With Therapy-Related AMLJama-Journal Of The American Medical Association, 2011
- CREBBP mutations in relapsed acute lymphoblastic leukaemiaNature, 2011
- Distant metastasis occurs late during the genetic evolution of pancreatic cancerNature, 2010
- DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid LeukemiaCancer Cell, 2010
- Targeted capture and massively parallel sequencing of 12 human exomesNature, 2009
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem CellsCell, 2009
- The cancer genomeNature, 2009
- DNA sequencing of a cytogenetically normal acute myeloid leukaemia genomeNature, 2008
- Cancer genes and the pathways they controlNature Medicine, 2004